Evidence map›Paper›PMID 10816503›Full record

ArticleInfection and immunity2000

Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

M Lizotte-Waniewski, W Tawe, D B Guiliano, W Lu, J Liu, S A Williams, S Lustigman

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 96 citations in OpenAlex.

  1. Chromosome-ContiguousInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Identification and cloning of a novel tetraspanin (TSP) homologue from Brugia malayi.DNA sequence : the journal of DNA sequencing and mapping · 2008
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

M Lizotte-WaniewskiProgram in Molecular and Cellular Biology, University of Massachusetts, Amherst, Massachusetts, USA.
W Tawe
D B Guiliano
W Lu
J Liu
S A Williams
S Lustigman
New York Blood Center · USSmith College · USUniversity of Edinburgh · GBUniversity of Massachusetts Amherst · US

Funding

PROTECTIVE IMMUNITY IN HUMANS AGAINST O VOLVULUS LARVAER01AI042328 · NIAID · NEW YORK BLOOD CENTER · PI LUSTIGMAN, SARA · 1998 to 2001
$773k
NIAID NIH HHS R01 AI 42328-02
6 · The paper itself

Abstract

The search for appropriate vaccine candidates and drug targets against onchocerciasis has so far been confronted with several limitations due to the unavailability of biological material, appropriate molecular resources, and knowledge of the parasite biology. To identify targets for vaccine or chemotherapy development we have undertaken two approaches. First, cDNA expression libraries were constructed from life cycle stages that are critical for establishment of Onchocerca volvulus infection, the third-stage larvae (L3) and the molting L3. A gene discovery effort was then initiated by random expressed sequence tag analysis of 5,506 cDNA clones. Cluster analyses showed that many of the transcripts were up-regulated and/or stage specific in either one or both of the cDNA libraries when compared to the microfilariae, L2, and both adult stages of the parasite. Homology searches against the GenBank database facilitated the identification of several genes of interest, such as proteinases, proteinase inhibitors, antioxidant or detoxification enzymes, and neurotransmitter receptors, as well as structural and housekeeping genes. Other O. volvulus genes showed homology only to predicted genes from the free-living nematode Caenorhabditis elegans or were entirely novel. Some of the novel proteins contain potential secretory leaders. Secondly, by immunoscreening the molting L3 cDNA library with a pool of human sera from putatively immune individuals, we identified six novel immunogenic proteins that otherwise would not have been identified as potential vaccinogens using the gene discovery effort. This study lays a solid foundation for a better understanding of the biology of O. volvulus as well as for the identification of novel targets for filaricidal agents and/or vaccines against onchocerciasis based on immunological and rational hypothesis-driven research.

Indexed as

Expressed Sequence TagsGene LibraryAnimalsAntibodies, HelminthAntigens, HelminthEndopeptidasesFilaricidesGene Expression ProfilingGenes, HelminthHumansLarvaMolecular Sequence DataOnchocerca volvulusOnchocerciasisPeptidylprolyl IsomeraseReceptors, Cell SurfaceAntibodies, HelminthAntigens, HelminthEndopeptidasesFilaricidesPeptidylprolyl IsomeraseReceptors, Cell SurfaceReceptors, NeurotransmitterVaccines

Identifiers

PMID10816503
PMCPMC97634
OpenAlexW2131996281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.